Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19 Reply

被引：0
|
作者：
Vaduganathan, Muthiah [1 ]
Solomon, Scott D. [1 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 382卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea
    Son, Minkook
    Seo, Jeongkuk
    Yang, Sung
    HYPERTENSION, 2020, 76 (03) : 742 - 749
  • [32] A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19
    Usman, Muhammad Shariq
    Siddiqi, Tariq Jamal
    Khan, Muhammad Shahzeb
    Ahmed, Areeba
    Ali, Syed Saad
    Michos, Erin D.
    Hall, Michael E.
    Krasuski, Richard A.
    Greene, Stephen J.
    Butler, Javed
    Alkhouli, Mohamad
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 130 : 159 - 161
  • [33] Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors
    Golpe, Rafael
    Perez-de-Llano, Luis A.
    Dacal, David
    Guerrero-Sande, Hector
    Pombo-Vide, Beatriz
    Ventura-Valcarcel, Pablo
    MEDICINA CLINICA, 2020, 155 (11): : 488 - 490
  • [34] Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19
    Kutz, Alexander
    Conen, Anna
    Gregoriano, Claudia
    Haubitz, Sebastian
    Koch, Daniel
    Domenig, Oliver
    Bernasconi, Luca
    Mueller, Beat
    Schuetz, Philipp
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 184 (04) : 543 - 552
  • [35] Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19: A Meta-Analysis and Systematic Review
    Hassib, Mohab
    Hamilton, Steven
    Elkhouly, Ahmed
    Li, Yiting
    Kaplan, Adam C.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
  • [36] Impact of the withdrawal of renin-angiotensin-aldosterone inhibitors on mortality in COVID-19 patients
    Caro-Codon, Juan
    Rey, Juan R.
    Iniesta, Angel M.
    Rosillo, Sandra O.
    Castrejon-Castrejon, Sergio
    Rodriguez-Sotelo, Laura
    Garcia-Veas, Jose M.
    Marco, Irene
    Martinez, Luis A.
    Martin-Polo, Lorena
    Merino, Carlos
    Martinez-Cossiani, Marcel
    Buno, Antonio
    Gonzalez-Valle, Luis
    Herrero, Alicia
    Lopez-de-Sa, Esteban
    Merino, Jose L.
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2022, 41 (10) : 823 - 830
  • [37] Impact of renin–angiotensin–aldosterone system inhibitors on COVID-19
    Yasushi Matsuzawa
    Kazuo Kimura
    Hisao Ogawa
    Kouichi Tamura
    Hypertension Research, 2022, 45 : 1147 - 1153
  • [38] Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic
    Katsiki, Niki
    Banach, Maciej
    Mikhailidis, Dimitri P.
    ARCHIVES OF MEDICAL SCIENCE, 2020, 16 (03) : 485 - 489
  • [39] COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system
    Susanne Rysz
    Jonathan Al-Saadi
    Anna Sjöström
    Maria Farm
    Francesca Campoccia Jalde
    Michael Plattén
    Helen Eriksson
    Margareta Klein
    Roberto Vargas-Paris
    Sven Nyrén
    Goran Abdula
    Russell Ouellette
    Tobias Granberg
    Malin Jonsson Fagerlund
    Johan Lundberg
    Nature Communications, 12
  • [40] The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
    Mascolo, Annamaria
    Scavone, Cristina
    Rafaniello, Concetta
    De Angelis, Antonella
    Urbanek, Konrad
    di Mauro, Gabriella
    Cappetta, Donato
    Berrino, Liberato
    Rossi, Francesco
    Capuano, Annalisa
    FRONTIERS IN PHARMACOLOGY, 2021, 12
12345